Detection of muramyl dipeptide-sensing pathway defects in patients with Crohn's disease

van Heel, David A, Hunt, Karen A, King, Kathy, Ghosh, Subrata, Gabe, Simon M, Mathew, Christopher G, Forbes, Alastair and Playford, Raymond J (2006) Detection of muramyl dipeptide-sensing pathway defects in patients with Crohn's disease. Inflammatory Bowel Diseases, 12 (7). pp. 598-605. ISSN 1078-0998

Full text not available from this repository. (Request a copy)

Abstract

Crohn's disease is strongly associated with double mutations in NOD2/CARD15. Three common mutations (Arg702Trp, Gly908Arg, Leu1007fs) impair innate immune responses to bacterial muramyl dipeptide. Rare NOD2 variants occur, but it is difficult to both identify them and assess their functional effect. We assessed the true frequency of defective muramyl dipeptide sensing in Crohn's disease and developed a rapid diagnostic assay.

Item Type: Article
Uncontrolled Keywords: acetylmuramyl-alanyl-isoglutamine,crohn disease,cytokines,enzyme-linked immunosorbent assay,genotype,heterozygote,humans,immunosuppressive agents,inflammation,interleukin-1beta,interleukin-8,lipopolysaccharides,monocytes,mutation,sensitivity and specificity
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
University of East Anglia > Faculty of Medicine and Health Sciences > Research Groups > Gastroenterology and Gut Biology
University of East Anglia > Faculty of Medicine and Health Sciences > Research Groups > Nutrition
Depositing User: Pure Connector
Date Deposited: 06 Aug 2014 11:58
Last Modified: 25 Jul 2018 09:55
URI: https://ueaeprints.uea.ac.uk/id/eprint/49665
DOI: 10.1097/01.ibd.0000225344.21979.89

Actions (login required)

View Item